| NASDAQ OMX Stockholm: BIOG.B
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different strains of the lactic acid bacterium Lactobacillus reuteri (L. reuteri), which has health-enhancing effects. The company has two segments, namely, finished consumer products and component products. The company was founded by Jan Annwall and Peter Rothschild in 1990 and is headquartered in Stockholm, Sweden.